This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
It is a pleasure to witness so many studies and discussions at the ADA focused on enhancing cardiometabolic health and improving patient outcomes." Competence in selecting treatments for long-term obesity management rose from 43% pre-test to 95% post-test.
Attendees will gain valuable clinical insights and explore cutting-edge therapies aimed at improving overall health outcomes. “Dr. Singh, MBBS, FRCP, MBA Advances in Obesity Pharmacotherapy Louis J. Shiffman, MD CME Supported Session LDL Lowering Therapy Beyond Statin Supported by an educational grant from Esperion Therapeutics.
The 19th Annual CMHC was more than just CME/CE medical education—it ignited global collaboration and inspired groundbreaking innovations. After the reception, many attendees enjoyed dinner at the PME (Non-CME) Dinner Symposium or ventured to one of Boston’s trendy Back Bay eateries. Experts like Louis J.
As a leader in the field of research-based cardiometabolic health education, CMHC is proud to present its CME education outcomes study at ADA (American Diabetes Association) 2024 Scientific Sessions, which offers its education-focused agenda to a wide number of healthcare practitioners from all areas of the U.S.
The conference will equip health professionals with clinical strategies that promote comprehensive health and tools to harness new therapies to improve our collective health outcomes. The robust conference agenda begins with FDA updates and advancements in cardiorenal metabolic care.
SUMMIT Trial : Weekly subcutaneous tirzepatide showed significant reductions in CV death and HF-related events among patients with HFpEF and obesity. A global symposium on November 15 tackled disparities in access and outcomes, bringing multidisciplinary perspectives to the table. Earn 14 CME credits anytime on any device.
With the holiday season approaching and fall in full swing, it’s the perfect time to reaffirm our commitment to delivering excellent care, improving patient outcomes, and making the most of every available resource. cardiometabolic health CME/CE conference: the 19th Annual CMHC. In the U.S.,
This patient’s case presents a common and challenging scenario in primary care and endocrinology, where T2D, obesity, and metabolic dysfunction intersect with liver disease. This underscores the importance of early detection and management of both conditions to prevent severe outcomes.
Healthcare professionals should consider pharmacotherapy options that address T2D, obesity, and liver disease: Statins : Statins are first-line therapies for managing dyslipidemia and reducing cardiovascular risk in patients with MASH. This dual action makes tirzepatide a promising option for treating MASH in patients with T2D and obesity.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content